Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The Phase 1b/2a clinical trial (NCT04445831), which was sponsored by AC Immune SA (clinical-stage biopharmaceutical company), examined the safety, tolerability, and immunogenicity of two tau-targeted liposomal vaccines, namely ACI-35.030 and JACI-35.054, in the early stages of AD
2010;34 Suppl 1:S47-55
Developmental deficiency of the cholinergic system in congenitally hyperammonemic spf mice: effect of acetyl-L-carnitine
IGF-1 LR3, by extending IGF-1like signaling, is used to assess how sustained pathway activation affects the timing and quality of differentiation events
Reductions in A1c levels were similar in any duration of diabetes in DUAL-1 and 2
Retatrutide is the only triple receptor agonist in development for weight loss
